Document:

EX-10.6

 Exhibit 10.6 

JFROG LTD. 
 NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
 Adopted and approved [_____], and effective as of the
Effective Date
 JFrog Ltd. (the “Company”) believes that providing cash and equity compensation
to members of its Board of Directors (the “Board,” and members of the Board, the “Directors”) represents an effective tool to attract, retain and reward Directors who are not employees of the Company (the
“Non-Employee Directors”). This Non-Employee Director Compensation Policy (the “Policy”) is intended to formalize the
Company’s policy regarding cash compensation and grants of equity awards to its Non-Employee Directors. Unless otherwise defined herein, capitalized terms used in this Policy will have the
meaning given such term in the Company’s 2020 Share Incentive Plan, as amended from time to time (the “Plan”). Each Non-Employee Director will be solely responsible
for any tax obligations incurred by such Non-Employee Director as a result of the equity awards and cash and other compensation such Non-Employee
Director receives under this Policy. This Policy will be subject to the terms of the Company’s Compensation Policy for Executive Officers and Directors, as may be amended from time to time (the “Compensation Policy”),
including any aggregate limits on compensation in such Compensation Policy. 
 Subject to Section 9 of this Policy, this Policy
will become effective as of the effective date of the first registration statement that is filed by the Company and declared effective pursuant to Section 12(b) of the U.S. Securities Exchange Act of 1934, as amended, with
respect to any class of the Company’s securities (the “Registration Statement,” and such date, the “Effective Date”).

1.
CASH COMPENSATION

A. Annual Cash Retainers for Service as Non-Employee Director. As of
the Effective Date, each Non-Employee Director will be paid a cash retainer of $30,000 per year. There are no per meeting attendance fees for attending Board
meetings or meetings of any committee of the Board.
 B. Additional Annual Cash Retainers
for Service as Lead Non-Employee Director, Committee Chair and Committee Member. As of the Effective Date, each Non-Employee
Director who serves as the lead Non-Employee Director or the chair or a member of a committee of the Board will be eligible to earn additional annual fees as follows:

 

					
	 Lead Non-Employee Director:
	  	$	10,000	 
	 Audit Committee Chair:
	  	$	20,000	
	 Member of Audit Committee:
	  	$	10,000	 
	 Compensation Committee Chair:
	  	$	15,000	 
	 Member of Compensation Committee:
	  	$	6,000	 
	 Nominating and Governance Committee Chair:
	  	$	7,500	 
	 Member of Nominating and Governance Committee:
	  	$	4,000	 

 For clarity, each Non-Employee Director who serves
as the chair of a committee will receive only the additional annual fee as the chair of the committee and not the additional annual fee as a member of such committee while serving as such
chair, provided that the Non-Employee Director who serves as the Lead Non-Employee Director will receive the annual fee as an Non-Employee Director and the additional annual fee as the Lead Non-Employee Director. 

C. Payments. Each annual cash retainer under this Policy will be paid quarterly in arrears on a prorated basis to each Non-Employee Director who has served in the relevant capacity at any point during the immediately preceding fiscal quarter of the Company (“Fiscal Quarter”), and such payment will be
made no later than thirty (30) days following the end of such immediately preceding Fiscal Quarter. For purposes of clarity, an Non-Employee Director who has served as an Non-Employee Director, as a member of an applicable committee (or chair thereof) during only a portion of the relevant Fiscal Quarter will receive a prorated payment of the quarterly payment of the
applicable annual cash retainer(s), calculated based on the number of days during such Fiscal Quarter such Non-Employee Director has served in the relevant capacities. For purposes of clarity,
an Non-Employee Director who has served as an Non-Employee Director, as a member of an applicable committee (or chair thereof), as applicable, from the Effective Date
through the end of the Fiscal Quarter containing the Effective Date (the “Initial Period”) will receive a prorated payment of the quarterly payment of the applicable annual cash retainer(s), calculated based on the number
of days during the Initial Period that such Non-Employee Director has served in the relevant capacities. 

2. EQUITY COMPENSATION

Non-Employee Directors will be eligible to receive all types of Awards, other than Incentive Stock
Options (but including 102 Awards) under the Plan, including discretionary Awards not covered under this Policy. All grants of Awards to Non-Employee Directors pursuant to Section 2 of this
Policy will be automatic and nondiscretionary, except as otherwise provided herein, and will be made in accordance with the following provisions:

A. No Discretion. No person will have any discretion to select which Non-Employee
Directors will be granted any Awards under this Policy or to determine the number of Shares to be covered by such Awards, except as provided in Sections 2.E. and 9 below.

B. Initial Awards. Subject to the provisions of the Compensation Policy, each individual who first becomes an Non-Employee Director (either by election or appointment) following the Effective Date will be granted an equity award (an “Initial Award”) as follows: 

(i) First Year of Trading. With respect to each individual who first becomes an Non-Employee
Director following the Effective Date (either by election or appointment) but on or prior to the one (1) year anniversary of the Effective Date, the Initial Award will consist of Options (each, an “Initial Option Award”) to
purchase a number of Shares having a Value (as defined below) of $350,000, with any resulting fractional Share rounded down to the nearest whole Share. Such Options will be nonstatutory stock options for U.S. tax purposes. 

  
 -2- 

 (ii) After First Year of Trading. With respect to each individual who first becomes
an Non-Employee Director following the one (1) year anniversary of the Effective Date, the Initial Award will consist of RSUs (each, an “Initial RSU Award”) covering a number of Shares
having a Value of $350,000, with any resulting fractional Share rounded down to the nearest whole Share. 
 (iii) Terms. The Initial
Award will be granted automatically on the first trading day on or after the date on which such individual first becomes an Non-Employee Director (the first date as an Non-Employee Director, the “Initial Start Date”), whether through election by the Company’s shareholders or appointment by the Board to fill a vacancy. If an individual was
a member of the Board and also an employee, becoming an Non-Employee Director due to termination of employment will not entitle the Non-Employee Director to an
Initial Award. Subject to Section 4 of this Policy, each Initial Award will be scheduled to vest as follows, whether the Initial Award consists of an Initial Option Award or an Initial RSU
Award: one-twelfth (1/12th) of the Shares subject to the Initial Award will be scheduled to vest on each three (3) month
anniversary of the Non-Employee Director’s Initial Start Date on the same day of the month as such Initial Start Date (or on the last day of the month if there is no corresponding day in such month), in
each case subject to the Non-Employee Director continuing to be a Director through the applicable vesting date. 

C. Annual Awards. On the first trading day immediately following each Annual Meeting of the Company’s
shareholders (an “Annual Meeting”) that occurs after the Effective Date, each Non-Employee Director who has completed at least six (6) months of continuous service as an Non-Employee Director as of the date of such Annual Meeting automatically will be granted an award of RSUs (an “Annual Award”) covering a number of Shares having a Value of
$175,000, with any resulting fractional Share rounded down to the nearest whole Share. Subject to Section 4 of this Policy, each Annual Award will be scheduled to vest as follows:
one-fourth (1/4th) of the Shares subject to the Annual Award will be scheduled to vest on each three (3) month anniversary of the date of grant on the
same day of the month as such date of grant (or on the last day of the month if there is no corresponding day in such month), in each case subject to the Non-Employee Director continuing to be a Director
through the applicable vesting date. 
 D. Additional Terms of
Initial Awards and Annual Awards. The terms and conditions of each Initial Award and Annual Award will be as follows: 

i. The term of each Initial Option Award will be ten (10) years, subject to earlier termination as provided in the
Plan.
 ii. The exercise price per Share of each Initial Option Award will be equal to 100% of the Fair Market
Value per Share on such Initial Option Award’s grant date.

  
 -3- 

 iii. Each Initial Award and Annual Award will be granted under and subject to the terms and
conditions of the Plan and the applicable form of Award Agreement previously approved by the Board or its Compensation Committee, as applicable, for use thereunder.

iv. For purposes of this Policy, “Value” means the grant date fair value as determined in accordance with U.S. generally
accepted accounting principles, or such other methodology the Board and/or the compensation committee of the Board (the “Compensation Committee”), as applicable, may determine prior to the grant of the applicable Award
becoming effective. 
 v. Israeli Non-Employee Directors may be granted Initial Awards and Annual
Awards that qualify as 102 Awards.
 E. Revisions. The Board or the Compensation Committee, as required under
applicable law, may change and otherwise revise the terms of Initial Awards and Annual Awards granted under this Policy, including, without limitation, the number of Shares subject thereto and type of Award, subject to the
terms of the Compensation Policy and the provisions of the Companies Law – 5759-1999 and the regulations promulgated thereunder (the “Companies Law”).

3. OTHER COMPENSATION AND BENEFITS

Subject to the provisions of the Compensation Policy, Non-Employee Directors
also may be eligible to receive other compensation and benefits, as may be determined by the Board and/or its Compensation Committee, as applicable, from time to time, subject to the terms of the Compensation
Policy and the Companies Law.
 4. MERGER/SALE

In the event of a Merger/Sale, each Non-Employee Director will fully vest in his or her outstanding
Company equity awards as of immediately prior to a Merger/Sale, including any Initial Awards and Annual Awards, provided that the Non-Employee Director continues to be an Non-Employee Director through the date of the Merger/Sale. 
 5. TRAVEL
EXPENSES
 Each Non-Employee Director’s
reasonable, customary, and properly documented, out-of-pocket travel expenses to meetings of the Board and any of its committees,
as applicable, will be reimbursed by the Company, subject to and in accordance with the Company’s expense reimbursement policies as then in effect.

  
 -4- 

 6. ADJUSTMENTS

In the event that any dividend or other distribution (whether in the form of cash, Shares, other securities or other
property), recapitalization stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off,
combination, reclassification, repurchase, or exchange of Shares or other securities of the Company, or other change in the corporate structure of the Company affecting the Shares occurs (other than any ordinary dividends or other
ordinary distributions), the Board, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under this Policy, will adjust the number of Shares issuable pursuant to Awards granted under
this Policy.
 7. SECTION 409A

In no event will cash compensation or expense reimbursement payments under this Policy be paid after the later of (a) the fifteenth (15th) day of the third (3rd) month following the end of the Company’s taxable year in which the compensation is earned
or expenses are incurred, as applicable, or (b) the fifteenth (15th) day of the third (3rd) month following the end of
the calendar year in which the compensation is earned or expenses are incurred, as applicable, in compliance with the “short-term deferral” exception under Section 409A. It is the intent of this Policy that this
Policy and all payments hereunder be exempt from or otherwise comply with the requirements of Section 409A so that none of the compensation to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any
ambiguities or ambiguous terms herein will be interpreted to be so exempt or comply. In no event will the Company or its Affiliates have any responsibility, liability or obligation to reimburse, indemnify, or hold
harmless an Non-Employee Director or any other person for any taxes imposed, or other costs incurred, as a result of Section 409A.

8. SHAREHOLDER APPROVAL

The Company’s shareholders are required to approve this Policy prior to the Effective Date. Unless otherwise required by applicable law,
following the initial approval of this Policy by the Company’s shareholders prior to the Effective Date, payment of compensation and grants of awards to Non-Employee Directors pursuant to the
Policy will not be subject to approval by the Company’s shareholders.
 9.
REVISIONS
 Subject to the requirements of the Companies Law, including the
approval of the Company’s shareholders (if applicable), the Board and the Compensation Committee may amend, alter, suspend or terminate this Policy at any time and for any reason. No amendment, alteration, suspension or termination of this
Policy will materially impair the rights of an Non-Employee Director with respect to compensation that already has been paid or awarded, unless otherwise mutually agreed in
writing between the Non-Employee Director and the Company. Termination of this Policy will not affect the Board’s or the Compensation Committee’s ability to exercise the
powers granted to it with respect to Awards granted pursuant to this Policy prior to the date of such termination, including without limitation such applicable powers set forth in the Plan.

*            *           
 *

  
 -5-EX-10.7

 Exhibit 10.7 

JFROG, INC. 
 CHANGE IN
CONTROL AND SEVERANCE AGREEMENT 
 This Change in Control and Severance Agreement (the “Agreement”) is made between
JFrog, Inc. (the “Company”) and Shlomi Ben-Haim (the “Executive”), effective as of      , 2020 (the “Effective Date”). 

This Agreement provides certain protections to the Executive in connection with a change in control of the Company or in connection with the
involuntary termination of the Executive’s employment under the circumstances described in this Agreement. 
 The Company and the
Executive agree as follows: 
 1.    Term of Agreement. This Agreement will terminate upon the date that all of
the obligations of the parties hereto with respect to this Agreement have been satisfied. To the extent the Executive relocates to Israel, the Executive shall be engaged by JFrog Ltd., the Company’s parent company (the
“Parent”), and such engagement shall be made in accordance with and under the terms of the Parent’s executive form of employment agreement, and the terms covered by this Agreement shall be adjusted thereby, mutatis mutandis,
such that the employer-cost associated therewith shall remain as reflected by this Agreement. 
 2.    At-Will Employment. The Company and the Executive acknowledge that the Executive’s employment is and will continue to be at-will, as defined under applicable law.
Company’s expectation is for a ninety (90) day advance notice prior to end of employment. 
 3.    Severance
Benefits. 
 (a)    Qualifying Non-CIC Termination. On a Qualifying Non-CIC Termination (as defined below), the Executive will be eligible to receive the following payments and benefits from the Company: 

(i)    Salary Severance. A single, lump sum payment equal to twelve (12) months of the Executive’s
Salary (as defined below), less applicable withholdings. 
 (ii)    COBRA Coverage. Subject to
Section 3(d), the Company will pay the premiums for coverage under COBRA (as defined below) for the Executive and the Executive’s eligible dependents, if any, at the rates then in effect, subject to any subsequent changes in rates that are
generally applicable to the Company’s active employees (the “COBRA Coverage”), until the earliest of (A) a period of twelve (12) months from the date of the Executive’s termination of employment,
(B) the date upon which the Executive (and the Executive’s eligible dependents, as applicable) becomes covered under similar plans, or (C) the date upon which the Executive ceases to be eligible for coverage under COBRA. 

 (iii)    Relocation Severance. A single lump sum payment equal
to 35,000, less applicable withholdings, to assist with the Executive’s potential relocation from the United States to Israel. 

(b)    Qualifying CIC Termination. On a Qualifying CIC Termination, the Executive will be eligible to receive the
following payments and benefits from the Company: 
 (i)    Salary Severance. A single, lump sum payment equal
to eighteen (18) months of the Executive’s Salary, less applicable withholdings. 
 (ii)    Bonus
Severance. A single, lump sum payment equal to the product of (A) the Executive’s target annual bonus as in effect for the fiscal year in which the Qualifying CIC Termination occurs, multiplied by (B) a ratio where the
numerator is the number of full days during the fiscal year in which the Qualifying CIC Termination occurs that the Executive was employed by the Company and the denominator is three hundred and sixty five (365), less applicable withholdings. 

(iii)    COBRA Coverage. Subject to Section 3(d), the Company will provide COBRA Coverage until the earliest
of (A) a period of eighteen (18) months from the date of the Executive’s termination of employment, (B) the date upon which the Executive (and the Executive’s eligible dependents, as applicable) becomes covered under similar
plans, or (C) the date upon which the Executive ceases to be eligible for coverage under COBRA.. 

(iv)    Equity Vesting Acceleration. Vesting acceleration (and exercisability, as applicable) as to 100% of the
then-unvested shares subject to each of the Executive’s then-outstanding compensatory equity awards issued by the Parent. In the case of an equity award with performance-based vesting, unless otherwise specified in the applicable equity award
agreement governing such award, all performance goals and other vesting criteria will be deemed achieved at target. 

(v)    Relocation Severance. A single lump sum payment equal to 35,000, less applicable withholdings, to assist
with the Executive’s potential relocation from the United States to Israel. 
 (c)    Termination Other Than a
Qualifying Termination. If the termination of the Executive’s employment with the Company Group is not a Qualifying Termination, then the Executive will not be entitled to receive severance or other benefits. 

(d)    Conditions to Receipt of COBRA Coverage. The Executive’s receipt of COBRA Coverage is subject to the
Executive electing COBRA continuation coverage within the time period prescribed pursuant to COBRA for the Executive and the Executive’s eligible dependents, if any. If the Company determines in its sole discretion that it cannot provide the
COBRA Coverage without potentially violating, or being subject to an excise tax under, applicable law (including, without limitation, Section 2716 of the Public Health Service Act), then in lieu of any COBRA Coverage, the Company will provide
to the Executive a taxable monthly payment payable on the last day of a given month (except as provided by the immediately following sentence), in an amount equal to the monthly COBRA premium that the Executive would be required to pay to continue
his or her group health coverage in effect on the date of his or her Qualifying Termination (which amount will be based on the 

  
 - 2 - 

 
premium rates applicable for the first month of COBRA Coverage for the Executive and any of eligible dependents of the Executive) (each, a “COBRA Replacement Payment”), which
COBRA Replacement Payments will be made regardless of whether the Executive elects COBRA continuation coverage and will end on the earlier of (x) the date upon which the Executive obtains other employment or (y) the date the Company has
paid an amount totaling the number of COBRA Replacement Payments equal to the number of months in the applicable COBRA Coverage period. For the avoidance of doubt, the COBRA Replacement Payments may be used for any purpose, including, but not
limited to continuation coverage under COBRA, and will be subject to any applicable withholdings. Notwithstanding anything to the contrary under this Agreement, if the Company determines in its sole discretion at any time that it cannot provide the
COBRA Replacement Payments without violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Executive will not receive the COBRA Replacement Payments or any further COBRA Coverage. 

(e)    Non-Duplication of Payment or Benefits. For purposes of clarity, in the event of a Qualifying Pre-CIC Termination, any severance payments and benefits to be provided to the Executive under Section 3(b) will be reduced by any amounts that already were provided to the Executive under
Section 3(a). Notwithstanding any provision of this Agreement to the contrary, if the Executive is entitled to any cash severance, continued health coverage benefits, or vesting acceleration of any equity awards (other than under this
Agreement) by operation of applicable law or under a plan, policy, contract, or arrangement sponsored by or to which any member of the Company Group is a party (“Other Benefits”), then the corresponding severance payments and
benefits under this Agreement will be reduced by the amount of Other Benefits paid or provided to the Executive. 

(f)    Death of the Executive. In the event of the Executive’s death before all payments or benefits the
Executive is entitled to receive under this Agreement have been provided, the unpaid amounts will be provided to the Executive’s designated beneficiary, if living, or otherwise to the Executive’s personal representative in a single lump
sum as soon as possible following the Executive’s death. 
 (g)    Transfer Between Members of the Company
Group. For purposes of this Agreement, if the Executive is involuntarily transferred from one member of the Company Group to another, the transfer will not be a termination without Cause but may give the Executive the ability to resign for Good
Reason. 
 (h)    Exclusive Remedy. In the event of a termination of the Executive’s employment with the
Company Group, the provisions of this Agreement are intended to be and are exclusive and in lieu of any other rights or remedies to which the Executive may otherwise be entitled, whether at law, tort or contract, or in equity. The Executive will be
entitled to no benefits, compensation or other payments or rights upon termination of employment other than those benefits expressly set forth in this Agreement. 

4.    Accrued Compensation. On any termination of the Executive’s employment with the Company Group, the
Executive will be entitled to receive all accrued but unpaid vacation, expense reimbursements, wages, and other benefits due to the Executive under any Company-provided plans, policies, and arrangements. 

  
 - 3 - 

 5.    Conditions to Receipt of Severance. 

(a)    Separation Agreement and Release of Claims. The Executive’s receipt of any severance payments or
benefits upon the Executive’s Qualifying Termination under Section 3 is subject to the Executive signing and not revoking the Company’s then-standard separation agreement and release of claims (which may include an agreement not to
disparage any member of the Company Group, non-solicit provisions, an agreement to assist in any litigation matters, and other standard terms and conditions) (the “Release” and that
requirement, the “Release Requirement”), which must become effective and irrevocable no later than the sixtieth (60th) day following the Executive’s Qualifying Termination
(the “Release Deadline”). If the Release does not become effective and irrevocable by the Release Deadline, the Executive will forfeit any right to severance payments or benefits under Section 3. 

(b)    Payment Timing. Any lump sum Salary, bonus or relocation payments under Sections 3(a)(i), 3(a)(iii),
3(b)(i), 3(b)(ii) and 3(b)(v) will be provided on the first regularly scheduled payroll date of the Company following the date the Release becomes effective and irrevocable (the “Severance Start Date”), subject to any delay required
by Section 5(d) below. Any taxable installments of any COBRA-related severance benefits that otherwise would have been made to the Executive on or before the Severance Start Date will be paid on the Severance Start Date, and any remaining
installments thereafter will be provided as specified in the Agreement. Any restricted stock units, performance shares, performance units, and/or similar full value awards that accelerate vesting under Section 3(b)(iv) will be settled
(x) on a date no later than ten (10) days following the date the Release becomes effective and irrevocable, or (y) if later, in the event of a Qualifying Pre-CIC Termination, on a date no later
than the Change in Control. 
 (c)    Return of Company Property. The Executive’s receipt of any severance
payments or benefits upon the Executive’s Qualifying Termination under Section 3 is subject to the Executive returning all documents and other property provided to the Executive by any member of the Company Group (with the exception of a
copy of the Company employee handbook and personnel documents specifically relating to the Executive), developed or obtained by the Executive in connection with his or her employment with the Company Group, or otherwise belonging to the Company
Group. 
 (d)    Section 409A. The Company intends that all payments and benefits provided under this Agreement
or otherwise are exempt from, or comply with, the requirements of Section 409A of the Code and any guidance promulgated under Section 409A of the Code (collectively, “Section 409A”) so that none of the
payments or benefits will be subject to the additional tax imposed under Section 409A, and any ambiguities in this Agreement will be interpreted in accordance with this intent. No payment or benefits to be paid to the Executive, if any, under
this Agreement or otherwise, when considered together with any other severance payments or separation benefits that are considered deferred compensation under Section 409A (together, the “Deferred Payments”) will be paid or
otherwise provided until the Executive has a “separation from service” within the meaning of Section 409A. If, at the time of the Executive’s termination of employment, the Executive is a “specified employee” within the
meaning of Section 409A, then the payment of the Deferred Payments will be delayed to the extent necessary to avoid the imposition of the additional tax imposed under Section 409A, which generally means that the Executive will receive
payment on the first payroll date that occurs on or after the date that is 6 months and 1 day following the Executive’s termination of employment. 

  
 - 4 - 

 
The Company reserves the right to amend this Agreement as it considers necessary or advisable, in its sole discretion and without the consent of the Executive or any other individual, to comply
with any provision required to avoid the imposition of the additional tax imposed under Section 409A or to otherwise avoid income recognition under Section 409A prior to the actual payment of any benefits or imposition of any additional
tax. Each payment, installment, and benefit payable under this Agreement is intended to constitute a separate payment for purposes of U.S. Treasury Regulation Section 1.409A-2(b)(2). In no event will any
member of the Company Group reimburse, indemnify, or hold harmless the Executive for any taxes, penalties and interest that may be imposed, or other costs that may be incurred, as a result of Section 409A. 

(e)    Resignation of Officer and Director Positions. The Executive’s receipt of any severance payments or
benefits upon the Executive’s Qualifying Termination under Section 3 is subject to the Executive resigning from all officer and director positions with all members of the Company Group and the Executive executing any documents the Company
may require in connection with the same. 
 6.    Limitation on Payments. 

(a)    Reduction of Severance Benefits. If any payment or benefit that the Executive would receive from any
Company Group member or any other party whether in connection with the provisions in this Agreement or otherwise (the “Payment”) would (i) constitute a “parachute payment” within the meaning of Section 280G of
the Code and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then the Payment will be equal to the Best Results Amount. The “Best Results
Amount” will be either (x) the full amount of the Payment or (y) a lesser amount that would result in no portion of the Payment being subject to the Excise Tax, whichever of those amounts, taking into account the applicable
federal, state and local employment taxes, income taxes and the Excise Tax, results in the Executive’s receipt, on an after-tax basis, of the greater amount. If a reduction in payments or benefits
constituting parachute payments is necessary so that the Payment equals the Best Results Amount, reduction will occur in the following order: (A) reduction of cash payments in reverse chronological order (that is, the cash payment owed on the
latest date following the occurrence of the event triggering the Excise Tax will be the first cash payment to be reduced); (B) cancellation of equity awards that were granted “contingent on a change in ownership or control” within the
meaning of Section 280G of the Code in the reverse order of date of grant of the awards (that is, the most recently granted equity awards will be cancelled first); (C) reduction of the accelerated vesting of equity awards in the reverse
order of date of grant of the awards (that is, the vesting of the most recently granted equity awards will be cancelled first); and (D) reduction of employee benefits in reverse chronological order (that is, the benefit owed on the latest date
following the occurrence of the event triggering the Excise Tax will be the first benefit to be reduced). In no event will the Executive have any discretion with respect to the ordering of Payment reductions. The Executive will be solely responsible
for the payment of all personal tax liability that is incurred as a result of the payments and benefits received under this Agreement, and the Executive will not be reimbursed, indemnified, or held harmless by any member of the Company Group for any
of those payments of personal tax liability. 
 (b)    Determination of Excise Tax Liability. Unless the
Company and the Executive otherwise agree in writing, the Company will select a professional services firm (the “Firm”) to make all determinations required under this Section 6, which determinations will be conclusive and
binding 

  
 - 5 - 

 
upon the Executive and the Company for all purposes. For purposes of making the calculations required by this Section 6, the Firm may make reasonable assumptions and approximations
concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and the Executive will furnish to the Firm such information and documents as the Firm
reasonably may request in order to make determinations under this Section 6. The Company will bear the costs and make all payments for the Firm’s services in connection with any calculations contemplated by this Section 6. The
Company will have no liability to the Executive for the determinations of the Firm. 
 7.    Definitions. The
following terms referred to in this Agreement will have the following meanings: 
 (a)    “Affiliate”
means with respect to any person, any other person that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, such person (with the term “control” or “controlled
by” within the meaning of Rule 405 of Regulation C under the Securities Act of 1933, as amended). 

(b)    “Board” means the Parent’s Board of Directors. 

(c)    “Cause” means the occurrence of any of the following: (i) the Executive’s willful breach
of any obligations the Confidentiality Agreement; (ii) the Executive’s willful misconduct that is materially injurious to any member of the Company Group; (iii) the Executive’s conviction of, or plea of nolo contendere to,
a crime that constitutes a felony under applicable law or involving fraud, embezzlement or any other act of moral turpitude; provided that, with respect to clause (i) of this Section 7(c), if such conduct is susceptible to cure (as
determined by the Board in good faith), the Executive shall have failed to cure such Cause to the Company’s reasonable satisfaction within thirty (30) days of receipt of a written notice setting forth in reasonable detail the nature of
such Cause. In the event that the conduct constituting Cause with respect to clause (i) of this Section 7(c) is not subject to cure in the good faith determination of the Board, then the right to cure and applicable notice period will not
apply. 
 (d)     “Change in Board Event” means any time at which individuals who, as of the Effective
Date, constitute the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the Effective Date whose election, or
nomination for election by the Parent’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but
excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of
proxies or consents by or on behalf of a person other than the Board. 
 (e)     “Change in Control”
means the occurrence of any of the events: (i) a sale of all or substantially all of the assets of the Parent, or a sale (including an exchange) of all or substantially all of the shares of the Parent, to any person, or a purchase by a
shareholder of the Parent or by an Affiliate of such shareholder, of all the shares of the Parent held by all or substantially all other shareholders or by other shareholders who are not Affiliated with such acquiring party; (ii) a merger
(including, a reverse merger and a reverse triangular merger), consolidation, amalgamation or like transaction of the Parent 

  
 - 6 - 

 
with or into another corporation; (iii) a scheme of arrangement for the purpose of effecting such sale, merger, consolidation, amalgamation or other transaction; or (iv) a Change in
Board Event. Notwithstanding the foregoing, a transaction will not be deemed a Change in Control unless the transaction qualifies as a change in control event within the meaning of Section 409A. Further and for the avoidance of doubt, a
transaction will not constitute a Change in Control if: (i) its sole purpose is to change the jurisdiction of the Parent’s incorporation, or (ii) its sole purpose is to create a holding company that will be owned in substantially the
same proportions by the persons who held the Parent’s securities immediately before such transaction. 

(f)    “Change in Control Period” means the period beginning three (3) months prior to a Change in
Control and ending twelve (12) months following a Change in Control. 
 (g)    “COBRA” means the
Consolidated Omnibus Budget Reconciliation Act of 1985, as amended. 
 (h)    “Code” means the
Internal Revenue Code of 1986, as amended. 
 (i)    “Company Group” means the Parent and any
subsidiaries of the Parent (including, but not limited to, the Company). 
 (j)    “Confidentiality
Agreement” means the At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement executed by the Company and the Executive on . 

(k)    “Disability” means a total and permanent disability as defined in Section 22(e)(3) of the
Code. 
 (l)    “Good Reason” means the termination of the Executive’s employment with the Company
Group by the Executive in accordance with the next sentence after the occurrence of one or more of the following events without the Executive’s express written consent: (i) a material reduction of the Executive’s duties, authorities,
or responsibilities relative to the Executive’s duties, authorities, or responsibilities in effect immediately prior to the reduction; (ii) a reduction by a Company Group member in the Executive’s rate of annual base salary by more
than ten percent (10%); provided, however, that, a reduction of annual base salary that also applies to substantially all other similarly situated employees of the Company Group members by up to ten percent (10%) will not constitute “Good
Reason”; (iii) a material change in the geographic location of the Executive’s primary work facility or location by more than thirty-five (35) miles from the Executive’s then present location; provided, that a relocation to a
location that is within thirty-five (35) miles from the Executive’s then-present primary residence will not be considered a material change in geographic location, or (iv) failure of a successor corporation to assume the obligations
under this Agreement as contemplated by Section 8. In order for the termination of the Executive’s employment with a Company Group member to be for Good Reason, the Executive must not terminate employment without first providing written
notice to the Company of the acts or omissions constituting the grounds for “Good Reason” within ninety (90) days of the initial existence of the grounds for “Good Reason” and a cure period of thirty (30) days following
the date of written notice (the “Cure Period”), the grounds must not have been cured during that time, and the Executive must terminate the Executive’s employment within thirty (30) days following the Cure Period. 

  
 - 7 - 

 (m)    “Qualifying
Pre-CIC Termination” means a Qualifying CIC Termination that occurs prior to the date of the Change in Control. 

(n)    “Qualifying Termination” means a termination of the Executive’s employment either (i) by
a Company Group member without Cause (excluding by reason of Executive’s death or Disability) or (ii) by the Executive for Good Reason, in either case, during the Change in Control Period (a “Qualifying CIC Termination”)
or outside of the Change in Control Period (a “Qualifying Non-CIC Termination”). 

(o)    “Salary” means the Executive’s annual base salary as in effect immediately prior to the
Executive’s Qualifying Termination (or if the termination is due to a resignation for Good Reason based on a material reduction in base salary, then the Executive’s annual base salary in effect immediately prior to the reduction) or, if
the Executive’s Qualifying Termination is a Qualifying CIC Termination and the amount is greater, at the level in effect immediately prior to the Change in Control. 

8.    Successors. This Agreement will be binding upon and inure to the benefit of (a) the heirs, executors,
and legal representatives of the Executive upon the Executive’s death, and (b) any successor of the Company. Any such successor of the Company will be deemed substituted for the Company under the terms of this Agreement for all purposes.
For this purpose, “successor” means any person, firm, corporation, or other business entity which at any time, whether by purchase, merger, or otherwise, directly or indirectly acquires all or substantially all of the assets or business of
the Company. None of the rights of the Executive to receive any form of compensation payable pursuant to this Agreement may be assigned or transferred except by will or the laws of descent and distribution. Any other attempted assignment, transfer,
conveyance, or other disposition of the Executive’s right to compensation or other benefits will be null and void. 

9.    Notice. 

(a)    General. All notices and other communications required or permitted under this Agreement shall be in writing
and will be effectively given (i) upon actual delivery to the party to be notified, (ii) upon transmission by email, (iii) twenty-four (24) hours after confirmed facsimile transmission, (iv) one (1) business day after
deposit with a recognized overnight courier, or (v) three (3) business days after deposit with the U.S. Postal Service by first class certified or registered mail, return receipt requested, postage prepaid, addressed (A) if to the
Executive, at the address the Executive shall have most recently furnished to the Company in writing, (B) if to the Company, at the following address: 

JFrog, Inc. 
 270 E. Caribbean
Drive 
 Sunnyvale, CA 94089 

Attention: General Counsel 

(b)    Notice of Termination. Any termination by a Company Group member for Cause will be communicated by a notice
of termination to the Executive, and any termination by the Executive for Good Reason will be communicated by a notice of termination to the Company, in each case given in accordance with Section 9(a) of this Agreement. The notice will indicate
the specific termination provision in this Agreement relied upon, will set forth in reasonable detail the facts and circumstances 

  
 - 8 - 

 
claimed to provide a basis for termination under the provision so indicated, and will specify the termination date (which will be not more than thirty (30) days after the later of
(i) the giving of the notice or (ii) the end of any applicable cure period). 
 10.    Resignation. The
termination of the Executive’s employment for any reason will also constitute, without any further required action by the Executive, the Executive’s voluntary resignation from all officer and/or director positions held at any member of the
Company Group, and at the Board’s request, the Executive will execute any documents reasonably necessary to reflect the resignations. 

11.    Miscellaneous Provisions. 

(a)    No Duty to Mitigate. The Executive will not be required to mitigate the amount of any payment contemplated
by this Agreement, nor will any payment be reduced by any earnings that the Executive may receive from any other source except as specified in Section 3(e). 

(b)    Waiver; Amendment. No provision of this Agreement will be modified, waived or discharged unless the
modification, waiver or discharge is agreed to in writing and signed by an authorized officer of the Company (other than the Executive) and by the Executive. No waiver by either party of any breach of, or of compliance with, any condition or
provision of this Agreement by the other party will be considered a waiver of any other condition or provision or of the same condition or provision at another time. 

(c)    Headings. All captions and section headings used in this Agreement are for convenient reference only and do
not form a part of this Agreement. 
 (d)    Entire Agreement. This Agreement constitutes the entire agreement of
the parties and supersedes in their entirety all prior representations, understandings, undertakings or agreements (whether oral or written and whether expressed or implied) of the parties with respect to the subject matter of this Agreement,
including, for the avoidance of doubt, any other employment letter or agreement, severance policy or program, or equity award agreement. 

(e)    Choice of Law. This Agreement will be governed by the laws of the State of California without regard to
California’s conflicts of law rules that may result in the application of the laws of any jurisdiction other than California. To the extent that any lawsuit is permitted under this Agreement, Employee hereby expressly consents to the personal
and exclusive jurisdiction and venue of the state and federal courts located in California for any lawsuit filed against the Executive by the Company. 

(f)    Arbitration. Any and all controversies, claims, or disputes with anyone under this Agreement (including the
Company and any employee, officer, director, stockholder or benefit plan of the Company in their capacity as such or otherwise) arising out of, relating to, or resulting from the Executive’s employment with the Company Group, shall be subject
to arbitration in accordance with the provisions of the Confidentiality Agreement. 

  
 - 9 - 

 (g)    Severability. The invalidity or unenforceability of any
provision or provisions of this Agreement will not affect the validity or enforceability of any other provision of this Agreement, which will remain in full force and effect. 

(h)    Withholding. All payments and benefits under this Agreement will be paid less applicable withholding taxes.
The Company is authorized to withhold from any payments or benefits all federal, state, local, and/or foreign taxes required to be withheld from the payments or benefits and make any other required payroll deductions. No member of the Company Group
will pay the Executive’s taxes arising from or relating to any payments or benefits under this Agreement. 

(i)    Counterparts. This Agreement may be executed in counterparts, each of which will be deemed an original, but
all of which together will constitute one and the same instrument. 
 [Signature page follows.] 

  
 - 10 - 

 By its signature below, each of the parties signifies its acceptance of the terms of this
Agreement, in the case of the Company by its duly authorized officer. 
  

							
	COMPANY	 		 	JFROG, INC.
				
		 		 	By:	 	  

				
		 		 	Title: 	 	  

				
		 		 	Date:	 	  

			
	EXECUTIVE	 		 	  

				
		 		 	Date:	 	  

  
 - 11 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}]]